UNSPSC 85522476: Dilation of right face vein with intraluminal device, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to dilation of right face vein with intraluminal device, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 057T3DZ

UNSPSC 85522476 Dilation of right face vein with intraluminal device, percutaneous approach is a Commodity code that shows no meaningful activity in recent state and local procurement. The code nominally describes a clinical procedure, yet the recent opportunities tagged under it span occupational health surveillance, pharmacy benefit management, temporary health professional staffing pools, and disability retirement medical evaluations — none of which involve dilation of facial veins or intraluminal interventions. The mismatch between the code's procedural specificity and the actual work being solicited suggests either miscategorization in the source data or that state and local procurement offices are applying this code inconsistently to health-care-related services that fall well outside its intended scope.

The identified recent opportunities originate from a mix of state agencies (Washington State Department of Transportation), counties (Collier County in Florida, Harris County in Texas, Santa Clara County in California), and cities (Phoenix, Long Beach). None of these solicitations target the clinical procedure named in the code. The Washington State Ferries occupational medical surveillance RFP (due October 9, 2026) and the City of Phoenix disability retirement medical evaluation RFP (due October 16, 2026) represent the closest administrative health-services work, but they address occupational examinations and disability assessments, not vascular interventions. Given the disconnect between the code and the actual scope of work in flight, this code does not present a clear or actionable procurement opportunity for vendors in any clinical device or vascular-intervention sector.